Core Viewpoint - Beijing Tongrentang Co., Ltd. is implementing a core strategy of "inheriting essence and innovating with integrity," focusing on cultural empowerment, digital intelligence, professional collaboration, and quality foundation in its marketing approach [1][2]. Group 1: Cultural Empowerment - The company is breaking traditional cultural dissemination models by creating a "Traditional Chinese Medicine Health Culture IP" centered around the "Qingxin Jiannao Huoluo Exercise," which aims to establish a closed-loop operation of "cultural awareness - user education - product scenario binding" [4]. - This initiative targets the elderly population, providing practical "preventive healthcare" solutions through a platform that covers 14 core cities and nearly 2 million elderly families [4]. - Collaborations with organizations like the China Marriage and Family Research Association and the China Elderly Sports Association enhance community engagement and service offerings [4]. Group 2: Digital Intelligence - The company is accelerating its digital transformation to enhance operational efficiency and user service, establishing a "data-driven, intelligent collaboration" marketing model [6]. - A digital marketing decision-making platform has been developed to collect data across various dimensions, enabling real-time market trend analysis and dynamic optimization of marketing strategies [6]. - The launch of an AI-driven health service platform in collaboration with Xiaomi aims to lower barriers for users seeking TCM services and effectively reach younger consumers [7]. Group 3: Professional Collaboration - The company is focusing on grassroots medical services as a key area for market expansion, creating a collaborative ecosystem among enterprises, medical institutions, and grassroots practitioners [8]. - The "Strong Foundation Cultivation of Chinese and Western Medicine" project aims to ensure high-quality training for practitioners through a structured selection and training process [8][9]. Group 4: Quality Foundation - Quality is emphasized as the lifeline of the brand, with a comprehensive supply chain quality control system established from sourcing to production and end-user traceability [10]. - The company adheres to strict standards in sourcing, particularly with its Jilin ginseng, which has received multiple organic certifications, ensuring high-quality products [10]. - A traceability system allows consumers to access detailed information about the entire process of herbal medicine, reinforcing trust in the brand's quality [10].

社会价值投资联盟（深圳）党支部书记、秘书长王思介绍，"生机计划"各个项目总筛查人数超过了17万 人次，覆盖受众规模超过17万人，合作机构达到275家。提质提效方面，已经有效提升了乳腺癌的日均 筛效率和先心病检测的准确率。在健康人群素养方面，项目在孕妇产前心理干预、儿童牙病防治等领域 做出了有益探索。 大会评选出"健康普惠筑基项目"4个，"健康数智创新项目"4个，"社会价值先锋项目"4个，"可持续妇幼 健康项目"5个。其中，"健康普惠筑基项目"有《"山中雏菊 筑梦同行"儿童口腔健康公益项目》《人工智 能辅助乳腺癌筛查技术在低资源地区应用示范研究》《低卫生资源地区肢体发育缺陷综合防控及救助示 范研究》《构建数字化多模态儿童疑难罕见病多学科会诊平台》，"健康数智创新项目"有《接受产前诊 断服务孕妇的社会心理支持模式研究——基于移动医疗手段的干预方法及应用》《数字化赋能的一体化 孕产妇心理健康服务模式构建》《重大先天性结构畸形防治智慧系统》《智能体音大模型：儿童健康管 理的新范式探索》，"社会价值先锋项目"有《手语传情——AI助力听障女性洞见"妇女两癌"》《巨细胞 病毒性视网膜炎早期公益筛查》《基于"敏云诊疗"数字化 ...

Group 1: Technology Engine - The core driving forces of industry upgrades are artificial intelligence, big data, and cloud computing, which are penetrating various sectors from smart manufacturing to public services [2] - There is a growing demand for high-end digital technology talent, particularly in fields such as AI, computer science, data science, cybersecurity, and IoT [2] Group 2: New Energy and Low-Carbon Environmental Protection - The "dual carbon" goals (peak carbon emissions by 2030 and carbon neutrality by 2060) are reshaping China's energy structure and industrial logic [3] - The transition to new energy sources, low-carbon technology development, and circular economy are becoming inevitable trends, supported by strong policies and expanding market demand [3] - Employment opportunities are emerging across energy production, engineering construction, and environmental governance [3] Group 3: Biomedicine and Health Sciences - The "Healthy China 2030" strategy is driving rapid development in fields such as precision medicine, genetic technology, and biopharmaceuticals [5] - Professionals with both research capabilities and practical experience will be the core competitive force in the healthcare industry [5] - Recommended fields include biomedical engineering, biotechnology, public health, and health management [5] Group 4: Intelligent Manufacturing and Industrial Internet - The essence of Industry 4.0 is to inject "soul" into manufacturing, leading to the inevitable transformation towards intelligent and digital manufacturing [6] - There is a significant talent gap in fields such as intelligent manufacturing engineering, industrial engineering, and robotics [6] Group 5: Modern Agriculture and Smart Agriculture - The rural revitalization strategy is promoting the transition from traditional agriculture to smart production [8] - Areas such as agricultural information technology and rural e-commerce present substantial potential for graduates [8] - Recommended fields include smart agriculture, agricultural information technology, and agricultural economics [8] Group 6: Cross-Disciplinary and Composite Professions - The future demand is for "bridge-type" talents who can integrate technology with industry, rather than single-domain experts [9] - Emerging interdisciplinary fields include AI in medicine, new energy materials, fintech, and pollution control technology [9] Group 7: Practical Tips for Choosing Schools and Majors - Interest is highlighted as the best teacher, emphasizing the importance of choosing fields that are not only promising but also enjoyable [11] - Mastery of foundational subjects like mathematics and physics is crucial for future adaptability in various popular majors [11] - Attention should be given to universities with unique disciplines, especially non-elite institutions in specific niches that offer high-quality employment resources [11]

Core Viewpoint - The company Tong Ren Tang, with a history of over 350 years, is actively reforming its marketing strategies to remain competitive in the market, focusing on innovative approaches to engage younger consumers and enhance brand recognition [1][2][3]. Group 1: Marketing Strategies - Tong Ren Tang has implemented a "saturation-free" marketing strategy, which has been recognized with an award for innovation in state-owned enterprise reform [1]. - The company is focusing on a "big variety" strategy for its well-known products, enhancing its marketing system and channel construction to adapt to new market conditions [2]. - The brand has successfully created IP images such as "Yuan Zong" and "Bai Feng," which resonate with consumers, leading to significant exposure and increased product awareness [3]. Group 2: Product Development and Cultural Integration - The "Royal Medicine Legend" product series has been launched, featuring upgrades in raw materials, packaging, and adherence to traditional manufacturing standards, aiming to provide higher quality and healthier options [3]. - A cultural exhibition titled "Royal Medicine Legend" has been organized to showcase the history of Tong Ren Tang's royal medicine, promoting traditional Chinese medicine culture [3]. Group 3: Digital Transformation and Consumer Engagement - The company has developed a data visualization platform that utilizes big data and AI to enhance marketing management and decision-making processes [4]. - An AI-driven health service platform, in collaboration with Xiaomi, has been introduced to provide personalized health advice and medication safety recommendations through mobile devices [4]. Group 4: Cultural Promotion and Heritage - Tong Ren Tang is committed to promoting traditional Chinese medicine culture through participation in various exhibitions and the establishment of a cultural display center [7]. - The company has initiated programs to preserve traditional manufacturing techniques and knowledge, including the establishment of a national-level workshop for traditional medicine artisans [8].

Core Insights - The article highlights the participation of Zeiss at the 8th China International Import Expo, emphasizing its commitment to innovation and visual health solutions [1][2][4] - Zeiss has shifted its strategy from being a "technology leader" to an "ecosystem builder," focusing on user-centered solutions for various demographics, particularly youth and the elderly [1][4][5] - The company aims to contribute to the "Healthy China 2030" vision by enhancing its brand philosophy of "innovation, precision, and social responsibility" [2][11] Company Strategy - Zeiss has introduced localized products such as the "Growth Eye" lens for youth myopia prevention and the "Lai Guang 2.0" progressive lens for the elderly, showcasing a shift from product-centric to user-centric approaches [4][5] - The company actively participates in industry standard-setting and digital collaboration, expanding its influence and operational depth in China [1][9][10] Product Innovations - The "Growth Eye" lens, utilizing dual patented technology, aims to effectively manage myopia in youth, with clinical trials indicating significant results in slowing myopia progression [4][5] - The "Lai Guang 2.0" lens offers customized solutions for the elderly, addressing the dual challenges of myopia and presbyopia [5] Collaborations and Partnerships - During the expo, Zeiss established strategic partnerships with Tianjin Eye Hospital and Huaxia Eye Hospital, focusing on enhancing service capabilities and creating a comprehensive eye health service ecosystem [6][7] - These collaborations emphasize resource integration and capability complementarity, aiming to elevate service standards in the eye health industry [7] Industry Contributions - Zeiss is committed to building a sustainable eye health service ecosystem in China, responding to the increasing demand for professional services and technological innovation in the visual health sector [9][10] - The company has initiated the "Guarding Big Eyes" public welfare project in collaboration with the China Youth Development Foundation, promoting eye health awareness and services [10] Future Outlook - Zeiss plans to continue its diversified business layout and enhance high-quality lifelong vision health solutions, aligning with market demands and the "Healthy China 2030" strategy [11]

非遗技艺融合现代科技，长森源产品引发现场关注 本次参展不仅是长森源品牌实力的一次集中展示，也被视为其对"健康中国2030"规划纲要的积极践行。 品牌方表示，未来将以此次博览会为新的起点，持续投入科研创新，严控产品品质，致力于为全国消费 者提供更优质的红参健康产品，并将中国红参的健康价值传递给更广泛的群体。 2025年11月7日，第六届中国（重庆）大健康产业博览会于重庆国际博览中心正式开幕。国内红参行业 知名品牌"长森源"受邀参展，携其核心产品红参浸膏在盛会中亮相，向海内外客商展示了中国红参的现 代化创新成果。 本届博览会作为大健康领域的重要代表，成功搭建了产业高端对话与前沿成果展示平台。据悉，现场汇 聚了超过600家海内外优质企业，并设立了中医中药、营养保健、生物医药等多个专业化主题展区。众 多行业专家、企业领袖及学者齐聚一堂，共探市场趋势与政策机遇，使本届展会成为推动成渝地区乃至 全国大健康产业发展的焦点盛事。 行业盛会启幕，共绘健康产业新蓝图 在备受瞩目的"中医药、艾灸及滋补养生展区"，"长森源"作为农业产业化国家重点龙头企业，其展出的 红参浸膏产品吸引了众多参展商与专业观众的驻足交流。据介绍，该产品深度 ...

Core Viewpoint - The health industry is experiencing significant growth, with new brands driving this expansion by integrating health into everyday life and consumer experiences [4][5][6]. Group 1: Health Industry Trends - The health sector is evolving, with a shift from general wellness to precision health, focusing on specific needs such as acne treatment, sleep aid, and emotional management [7][8]. - Consumers are increasingly seeking products that provide tangible experiences and emotional satisfaction, moving beyond mere functionality [9]. - Young women are identified as the primary growth drivers in the health industry, emphasizing the importance of both product efficacy and brand alignment with lifestyle [9][10]. Group 2: Brand Development and Support - New brands face challenges in transitioning from initial success to sustainable growth, requiring a balance of research capabilities and effective consumer communication [11][12]. - Tmall's "Treasure New Brand" initiative supports emerging brands through systematic measures, enhancing their market presence and long-term viability [12][30]. - Successful brands leverage unique product offerings and innovative marketing strategies to resonate with consumers, as seen with Swisse Me and its engaging approach to probiotics [14][15][17]. Group 3: Market Opportunities - The health market is diversifying, with brands exploring niche segments that combine health with lifestyle, such as emotional wellness and functional foods [33][34]. - The growth of the health industry is driven by a collaborative ecosystem involving research institutions, supply chains, and consumer insights, leading to a more structured approach to brand development [34][35]. - The ongoing trend towards health consciousness indicates that the market will continue to expand, with a focus on scientific and sustainable consumer care [36].

Group 1 - AstraZeneca showcased a strong commitment to innovation and sustainable development at the China International Import Expo, with a 1,000 square meter booth and over 30 events [2] - The company announced an additional investment of approximately $136 million in a Qingdao inhalation aerosol production project to meet clinical needs for asthma and COPD patients, reflecting its deepening engagement in the Chinese market [4] - AstraZeneca has cumulatively invested over $1.8 billion in China, with the opening of its second strategic R&D center in Beijing, which is part of a $2.5 billion investment plan [4] Group 2 - The company displayed over 40 innovative drugs and plans to accelerate the introduction of new drugs in chronic diseases, oncology, and rare diseases over the next two years [6] - AstraZeneca hosted over 30 events during the expo, including the launch of the "Health Day" series and patient care forums, focusing on innovative treatment pathways and payment models in various therapeutic areas [6] - The company emphasizes sustainable development across its entire value chain, with significant achievements in its production bases in Wuxi, Taizhou, and Qingdao, including a 100% renewable energy usage in Wuxi and a 97.5% reduction in carbon emissions at the Taizhou base compared to 2015 [8] Group 3 - AstraZeneca is committed to contributing to the "Healthy China 2030" goal by collaborating with various stakeholders to promote high-quality development in the Chinese healthcare industry [8]

在前七届进博会上，嘉吉已成功将众多创新成果推向中国市场，并累计签署超过300亿美元的合作 意向协议。今年，嘉吉依托进博会平台持续深化其在中国市场的产业共赢网络，与各行业伙伴在谷物、 牛肉、动物营养、铁矿石等领域签署多项战略采购与重要合作协议，预计签约总金额将超过30亿美元。 刘畅表示，作为一家在华深耕多年的跨国企业，嘉吉深切感受到中国持续优化营商环境、推进高水 平对外开放的决心，这为企业带来了更广阔的市场机遇与政策红利。近年来，"稳外资20条"等政策的落 地，显著增强了外资企业在华经营的确定性与便利性，对嘉吉这样注重产品与技术创新的企业而言，这 意味着开放之门更宽，创新之路更畅。 "中国始终是嘉吉重要的市场之一，嘉吉深耕中国市场已超过五十年，持续探索新的方式以服务亚 洲不断增长的食品和农业市场。我们将继续加大对中国市场的投入，坚持以客户为中心，深化在创新、 人才与可持续发展等关键领域的布局，助力中国农业与食品行业提升新质生产力，推动高质量、可持续 发展。"刘畅表示。 中证报中证网讯（记者 连润）11月5日至10日，第八届中国国际进口博览会在上海举办。作为进博 会的"全勤生"，今年嘉吉展示区面积达300平米，展 ...

Core Insights - The increasing prevalence of diabetes in China has made chronic disease prevention a key task in the "Healthy China 2030" strategy, with low GI diets gaining significant policy support and rapidly expanding industry scale [1][3] Industry Overview - The low GI food industry is experiencing rapid growth, with a diverse range of products and sales channels emerging, but it faces challenges such as intensified homogenization, insufficient core technology breakthroughs, and an incomplete innovation system [1] - The launch of the "Low GI Food and Health White Paper" aims to standardize the low GI food industry and promote deep integration of government, industry, academia, and research [3][18] Key Stakeholders - The event gathered representatives from various sectors, including government officials, industry leaders, and academic experts, highlighting the collaborative effort to advance the low GI food sector [1][3] - Key participants included prominent companies such as COFCO, Yihai Kerry, and Jiangnan Rice Road, which is a leader in the low GI functional rice industry [1][3] Expert Contributions - Academician Chen Junshi emphasized the need for a focus on grains in low GI food research and called for standardized production, enhanced government regulation, and consumer education to distinguish genuine products [3][5] - Zhao Tonggang highlighted the importance of establishing a scientific standard system for low GI foods to ensure safety and effectiveness, which is crucial for public health and the "Healthy China" initiative [7][9] Future Directions - The white paper will systematically address the relationship between carbohydrates and blood sugar, the scientific concepts of GI, and the current challenges in testing and certification [11][18] - Jiangnan Rice Road's president articulated a commitment to a full-chain approach in low GI rice production, ensuring both health benefits and taste quality, while actively participating in the white paper's development [16][18] - The collaborative efforts aim to create a multi-faceted ecosystem that integrates research, policy support, corporate practice, and consumer engagement to enhance national nutrition and health levels [18]